Manufactures and markets crop protection products (insecticides, herbicides, fungicides) and seeds for Indian agriculture. In FY26 the Agri Inputs segment generated Rs 2,876 cr (99.3% of revenue), with the remainder from 'Others' at Rs 21 cr. In Q1 FY27, revenue of Rs 1,022 cr split into Crop Care at Rs 697 cr (Domestic B2C +19% on 15% volume growth, Exports −28% on Chinese pricing pressure in acephate, pendimethalin and hexaconazole, CSM contract manufacturing +191%) and Seeds at Rs 325 cr (+6%), with Soil and Plant Health also up 10%. The seeds portfolio is being narrowed to five strategic crops — Cotton, Maize, Millet, Mustard and Rice — to offset weakness in cotton, where acreage is down 35% year-on-year. The company launched 4 new crop care products and 9 new seed varieties in the quarter, and its Anubandh Edge retailer network has crossed 56,000 registrations. Materials account for 54.5% of revenue, the largest cost line. Management has guided to 15%+ EBITDA margin consistently and 500 bps margin expansion over five years. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Agri Inputs (99%), Others (1%). Seasonal crop protection and seeds business tied to the Indian monsoon and crop acreage
| ₹ crore · consolidated | FY19 | FY20 | FY21 | FY22 |
|---|---|---|---|---|
| Revenue | 1,984 | 2,252 | 2,429 | 2,604 |
| EBITDA (ex other income) | 241 | 271 | 332 | 274 |
| margin % | 12.1 | 12.0 | 13.7 | 10.5 |
| Owners' profit | 155 | 185 | 229 | 164 |
| EPS, as reported (₹) | 7.99 | 9.51 | 11.75 | 8.44 |
| ROE % · ROCE % | 12.0 · 16.5 | 13.0 · 16.3 | 14.4 · 18.4 | 9.7 · 12.8 |
| Debt / equity (x) | 0.05 | 0.05 | 0.04 | 0.05 |
| Cash from operations | — | — | 217 | 166 |
| Capex | — | — | (143) | (156) |
| ₹ crore | Q1 FY21 | Q2 FY21 | Q3 FY21 | Q4 FY21 | Q1 FY22 | Q2 FY22 | Q3 FY22 | Q4 FY22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 663 | 725 | 570 | 471 | 741 | 728 | 628 | 508 |
| Profit before tax | 120 | 110 | 62 | 12 | 109 | 77 | 53 | (16) |
| Net profit | 92 | 83 | 46 | 8 | 82 | 56 | 40 | (14) |
| EPS (₹) | 4.72 | 4.27 | 2.35 | 0.42 | 4.23 | 2.90 | 2.03 | (0.73) |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| UPL LIMITED | 48,414 | 23.7 | 1.17 | 6.5 | 5.4 | 5.5 | 6.0 | 16.3 |
| PI INDUSTRIES LTD | 34,337 | 29.4 | 3.06 | 16.2 | 11.8 | 14.5 | 8.0 | 25.3 |
| SUMITOMO CHEM INDIA LTD | 23,762 | 41.0 | 7.00 | 29.6 | 16.0 | 20.8 | 4.1 | 28.9 |
| BAYER CROPSCIENCE LTD | 17,895 | 26.0 | 6.03 | — | 23.2 | 27.3 | — | 22.7 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 10 Sept 2026 · Rallis India schedules meetings with analysts and institutional investors | board shareholder meetings | low | — | — |
| 26 Aug 2026 · Rallis India schedules investor meetings from Sept 1 to Sept 21 | board shareholder meetings | low | — | — |
| 20 Aug 2026 · Rallis India CFO change: Sridhar Radhakrishnan replaces Bhaskar Swaminathan from Nov 4, 2026 | management changes | high | — | — |
| 20 Aug 2026 · CFO Bhaskar Swaminathan exits; Sridhar Radhakrishnan appointed new CFO | management changes | high | — | — |
| 10 Aug 2026 · Rallis India to hold one-on-one meetings with 4 investors in Aug 2026 | board shareholder meetings | low | — | — |
| 29 Jul 2026 · Special window for re-lodgement of physical share transfer requests | compliance | minimal | — | — |
| 27 Jul 2026 · Rallis India appoints SRBC as new statutory auditor from 2027 AGM | management changes | medium | — | — |
| 27 Jul 2026 · Q1FY27 Earnings Call: Revenue up 7% to about Rs 1,022 cr, EBITDA up 23% | investor communications | medium | — | — |
| 22 Jul 2026 · Newspaper advertisement of Q1 FY27 financial results | compliance | minimal | — | — |
| 22 Jul 2026 · Two Independent Directors complete their tenure at Rallis India | management changes | medium | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| SHARDA CROPCHEM LTD. |
| 6,910 |
| 11.0 |
| 2.20 |
| 5.7 |
| 21.7 |
| 25.2 |
| 17.1 |
| 20.5 |
| DHANUKA AGRITECH LTD | 4,359 | 14.9 | 3.11 | 9.7 | 21.2 | 27.0 | 12.7 | 27.4 |
| RALLIS INDIA LTD ◆ | 3,833 | 23.9 | 2.26 | 12.9 | 9.7 | 12.5 | — | 0.9 |
| NACL INDUSTRIES LIMITED | 3,709 | 310.4 | 5.43 | 45.4 | 0.7 | 1.4 | 5.9 | 11.3 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 23.9 | 20.1 | 18 of 27 | 35% |
| P/B | 2.3 | 2.4 | 14 of 28 | 52% |
| ROCE | 12.5 | 12.5 | 15 of 29 | 50% |
| ROE | 9.7 | 9.2 | 14 of 28 | 52% |
| Debt / Equity | 0.1 | 0.3 | 8 of 29 | 75% |
| EBITDA margin | 0.9 | 14.8 | 24 of 28 | 15% |
| Revenue growth | 7.7 | (0.8) | 9 of 28 | 70% |
| Profit growth | (274.3) | 18.1 | 28 of 28 | 0% |
| Market cap | 3833 | 1540 | 7 of 29 | 79% |
| A rating (BUY / ADD / REDUCE / SELL) |
| A state: the latest filed quarter and the measured reactions |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
